AccuSift provides high-performance competitive immunoassay antibody pairs for Diazepam with exceptional lot-to-lot consistency. Optimized for IVD kit development (Lateral Flow, CLIA, ELISA, POCT), these antibodies offer high affinity and specificity to facilitate rapid detection.
Diazepam is classified as a Schedule II controlled psychotropic substance.Clinically, it is used for: ① Anxiety disorders and various functional neuroses. ② Insomnia, especially effective for anxiety-related insomnia. ③ Epilepsy: It can be combined with other antiepileptic drugs to treat grand mal or petit mal seizures; intravenous injection is used to control status epilepticus. ④ Convulsions from various causes, such as eclampsia, tetanus, and febrile seizures in children. ⑤ Central muscle spasticity due to cerebrovascular accidents or spinal cord injuries, or muscle spasms caused by conditions like lumbar muscle strain and endoscopy. ⑥ Others: Migraine, tension headache, hiccups, reflex muscle spasms from inflammation, panic disorder, alcohol withdrawal syndrome; it can also treat familial, senile, and essential tremor, and is used for pre-anesthetic medication.On October 27, 2017, the World Health Organization's International Agency for Research on Cancer (IARC) published a preliminary list of carcinogens, with diazepam included in Group 3 (not classifiable as to its carcinogenicity to humans).
Sensitivity: ELISA IC₅₀ ≈ 0.1 ppb; Colloidal Gold: 0.5 ppb
Source: Mouse Monoclonal Antibody
Recommended Pairing: (Coating) / (Label)
Storage: Store at ≤ -20°C for long-term stability. Short-term storage at 2-8°C is acceptable. Shipped on ice packs.
WeChat
